Enduring Top Menu

Home

docsalltogether

Welcome to ForuMS!

ForuMS is an online journal club offered by the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and Catamount Medical Education. Each session will review 2 recent publications associated with Multiple Sclerosis.

This series has been developed with Patricia K. Coyle, MD, FAAN, FANA, Professor and Vice Chair of Clinical Affairs, Director of the MS Comprehensive Care Center at Stony Brook University Medical Center in Stony Brook, New York.

The live series portion of ForuMS has concluded, however, an online version of ForuMS is coming soon!

Topics include:
• MS and the Use of MRI and Biomarkers
• Comorbidities in MS and MS in Minority Populations
• Treatment of Relapsing Forms of MS
• Physical Activity and MS
• Vitamin D and MS
• Monitoring and Adverse Effects of MS Disease Modifying Therapies
• MS and Cognitive Dysfunction

Please be sure you are registered to receive regular updates on ForuMS.

To sign up to receive regular communications about ForuMS, please provide your first and last name as well as your email address. We will send you updates and reminders for the series.*

 

*Your email will not be provided or sold to parties not associated with this series.

CME/CNE Information

Needs Statement
This activity has been developed with the need to provide clinicians who manage patients with multiple sclerosis (MS) with up-to-date information on clinical advances in the diagnosis, treatment, and management of patients with the disease.

Learning Objectives
Upon completion of this series, participants should be able to:

  • Identify the latest research and clinical information available in the literature with regard to MS diagnosis, treatment, and monitoring
  • Review current and emerging disease-modifying therapies
  • Discuss optimal strategies for symptomatic and relapse management
  • Review the latest information relevant to the accurate and timely diagnosis of MS
  • Discuss strategies to address cognition, psychosocial, and quality of life issues in patients with MS
  • Identify the latest information available for the utilization of neuroimaging in MS patients for diagnosis and monitoring

Target Audience
The target audience for this activity is neurologists, nursing professionals, physician assistants, rehabilitation professionals, mental health specialists, case workers and other healthcare providers involved in the management of patients with MS.

Development Faculty
This series has been developed in coordination with Patricia K. Coyle, MD, FAAN, FANA, Professor and Vice Chair (Clinical Affairs); Director, MS Comprehensive Care Center, Stony Brook University Medical Center, Stony Brook, New York.

Accreditation and Credit Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and Catamount Medical Education. CMSC is accredited by the ACCME to provide continuing medical education for physicians.

CMSC designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. NPA designates each live activity for a maximum of 1.0 continuing nursing education credits.
Laurie Scudder, DNP, NP, has served as Nurse Planner for this activity. She has declared that she has no relevant financial relationships to disclose.

Support Acknowledgment
This series is supported by educational grants from Sanofi Genzyme, Mallinckrodt Pharmaceuticals, and Medtronic.

It is the policy of CMSC, NPA, and Catamount Medical Education to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. CMSC, NPA, and Catamount Medical Education have identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures
June Halper, MSN, APN-C, MSCN, FAAN, has disclosed that she serves as an unpaid consultant for non-CME research activity for Biogen. All other planners, reviewers, staff, or other members of the Continuing Professional Education Committee at the Consortium of Multiple Sclerosis Centers who control content have no relevant financial relationships to disclose.

The planners, reviewers, and staff at Nurse Practitioner Alternatives who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at Catamount Medical Education who control content have no relevant financial relationships to disclose.

Faculty Disclosures
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CE activity:

Patricia K. Coyle, MD has served as a consultant for AbbVie, Accordant, Acorda, Bayer, Biogen, Genentech/Roche, Genzyme, Mallinckrodt, Novartis, Serono, and Teva and has received grants/research support from Actelion, Genentech/Roche, Novartis, and Opexa. Dr. Coyle has also conducted contracted research for Actelion, Novartis, and Opexa.

Anthony Traboulsee, MD, has served as a consultant for Roche, Genzyme, Novartis, and Teva. Dr. Traboulsee has also conducted contracted research for Roche, Genzyme, Biogen, and Chugai Pharmaceutical Co, Ltd.

Mitzi Joi Williams, MD, has served as a consultant for Biogen, Teva Neuroscience, Novartis, Mallinckrodt and Genzyme. She has also served on the speakers bureau for Accorda, EMD Serono, Mallinckrodt, Novartis, Biogen, Teva and Genzyme.

Rebecca Farber, MD serves as an Editor of the Elsevier online Multiple Sclerosis Resource Center and is a MedPage reviewer.

Robert W. Motl, PhD has served as a consultant for Acorda Therapeutics and has conducted contracted research for Acorda Therapeutics, Sun Health Technologies, and Biogen. Dr. Motl has also served on the speakers bureau for EMD Serono.

Kathryn Fitzgerald, ScD has no relevant financial relationships to disclose.

Stephanie Agrella, MSN, APRN, ANP-BC, MSCN has served as a consultant for Sanofi Genzyme and Biogen, and on the Speakers Bureau for Acorda, Sanofi Genzyme, Teva, and Serono.

Elizabeth W. Triche, PhD has received consulting fees as a Steering Committee member from rEVO Biologics, Inc. and has conducted contracted research for Acorda Pharmaceuticals.

Disclosure of Unapproved Uses
CMSC, NPA, and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

 

X

Forgot Password?

Join Us